PREVENTION OF CHEMOTHERAPY-RELATED ANEMIA BY RECOMBINANT-HUMAN-ERYTHROPOIETIN (EPO) IN PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC) RECEIVING CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE (CAE) CHEMOTHERAPY WITHG-CSF SUPPORT

Authors
CRAWFORD J BLACKWELL S SHOEMAKER D PUPA MR MULHAUSEN T HERNDON J WINER E FLYNN J DEMPSEY H
Citation
J. Crawford et al., PREVENTION OF CHEMOTHERAPY-RELATED ANEMIA BY RECOMBINANT-HUMAN-ERYTHROPOIETIN (EPO) IN PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC) RECEIVING CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE (CAE) CHEMOTHERAPY WITHG-CSF SUPPORT, Blood, 84(10), 1994, pp. 10000129-10000129
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
84
Issue
10
Year of publication
1994
Supplement
1
Pages
10000129 - 10000129
Database
ISI
SICI code
0006-4971(1994)84:10<10000129:POCABR>2.0.ZU;2-7